# Study to Evaluate the Effects of AZD3427 in Patients With Heart Failure

> **NCT04890548** · PHASE1 · WITHDRAWN · sponsor: **AstraZeneca**

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** AZD3427

## Key facts

- **NCT ID:** NCT04890548
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-11-23
- **Primary completion:** 2022-08-02
- **Final completion:** 2022-08-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study start up timelines delayed into late autumn, and with COVID cases rising in the UK, the feasibility of successfully recruiting the study and ethical concerns about starting a study that AZ may not be able to complete.
- **Last updated:** 2021-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04890548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04890548, "Study to Evaluate the Effects of AZD3427 in Patients With Heart Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04890548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*